Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amedisys Inc
(NQ:
AMED
)
98.35
-0.10 (-0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amedisys Inc
< Previous
1
2
3
4
Next >
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q2 2024
July 24, 2024
AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024
April 24, 2024
AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
April 23, 2024
It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay.
Via
InvestorPlace
3 Stocks To Turn $1,000 Into $10,000 in 10 Years
January 12, 2024
There are a few simple rules for investing for 10x returns but they are among the most difficult to follow.
Via
InvestorPlace
3 Stocks Profiting from America’s Long-Term Care Crisis
November 22, 2023
These long-term care stocks provide older Americans with the care they need and the income to pay for it well into retirement.
Via
InvestorPlace
Is NASDAQ:AMED suited for quality investing?
August 14, 2023
AMEDISYS INC (NASDAQ:AMED) may be suited for quality investing, we'll explore why in this article.
Via
Chartmill
What 11 Analyst Ratings Have To Say About Amedisys
July 27, 2023
Via
Benzinga
Analyst Ratings for Amedisys
June 27, 2023
Via
Benzinga
Expert Ratings for Amedisys
June 06, 2023
Via
Benzinga
Cantor Fitzgerald Maintains Neutral Rating for Amedisys: Here's What You Need To Know
September 14, 2023
Via
Benzinga
The 3 Best Stock Picks for This Week
September 05, 2023
The best stock picks for this week have long-term aims such as high earnings and growth for your portfolio.
Via
InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)
August 08, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)
July 28, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
July 25, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
July 20, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Amedisys Inc. (NASDAQ: AMED) Near the Top of Equities by Percentage Gain on 6/5
June 05, 2023
Via
Investor Brand Network
Why Shares of Amedisys Are Jumping Monday
June 05, 2023
The home healthcare company received a buyout offer from a segment of UnitedHealth Group.
Via
The Motley Fool
Is UnitedHealth Group Stock a Buy Now?
July 11, 2023
The nation's largest health insurer has seen its shares fall despite a strong start to the year.
Via
The Motley Fool
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq – AMED)
July 10, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
July 06, 2023
Morgan Stanley cut the price target for ArcBest Corporation (NASDAQ: ARCB) from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at...
Via
Benzinga
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders
June 26, 2023
From
Halper Sadeh LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
July 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
June 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
June 28, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023
June 06, 2023
Via
Benzinga
Optum's Decision To Target Amedisys Is Intriguing, Says Analyst
June 05, 2023
Via
Benzinga
Why Shares Of Amedisys Inc Are Rising
June 05, 2023
Amedisys Inc (NASDAQ: AMED) shares are up Monday after the company announced that it received an unsolicited proposal from Optum, a diversified health services company, to acquire all of the...
Via
Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 05, 2023
Via
Benzinga
Amedisys Announces Receipt of Unsolicited Proposal From Optum
June 05, 2023
From
Amedisys, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.